Lixte Biotech Hlds (LIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Operating Expenses | 1,024 | 1,670 | 1,370 | 1,633 | 1,479 |
| Operating Income | -1,024 | -1,670 | -1,370 | -1,633 | -1,479 |
| Interest Expense | 0 | 2 | 4 | 4 | 2 |
| Other Income | 6 | 4 | 6 | 5 | 3 |
| Pre-tax Income | -1,019 | -1,668 | -1,368 | -1,631 | -1,478 |
| Net Income Continuous | -1,019 | -1,668 | -1,368 | -1,631 | -1,478 |
| Net Income | $-1,019 | $-1,668 | $-1,368 | $-1,631 | $-1,478 |
| EPS Basic Total Ops | -0.49 | -1.00 | -0.82 | -0.95 | -0.89 |
| EPS Basic Continuous Ops | -0.49 | -1.00 | -0.82 | -0.94 | -0.89 |
| EPS Diluted Total Ops | -0.49 | -1.00 | -0.82 | -0.95 | -0.89 |
| EPS Diluted Continuous Ops | -0.49 | -1.00 | -0.82 | -0.94 | -0.89 |
| EBITDA(a) | $-1,024 | $-1,670 | $-1,370 | $-1,633 | $-1,479 |